Editas Medicine Names James C. Mullen as Chairman of the Board …GlobeNewswire (press release)CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the appointment o… Continue reading
Editas Medicine Names James C. Mullen as Chairman of the Board …GlobeNewswire (press release)CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the appointment o… Continue reading
News@NortheasternNovel synthetic biology technique could lead to breakthroughs in disease treatmentNews@NortheasternSynthetic biology offers a vision for the future of medicine, where cells could be re-engineered to fight diseases such as cancer and di… Continue reading
News@NortheasternNovel synthetic biology technique could lead to breakthroughs in disease treatmentNews@NortheasternSynthetic biology offers a vision for the future of medicine, where cells could be re-engineered to fight diseases such as cancer and di… Continue reading
Cambridge Network |
Building the business of biodesign
Cambridge Network Synthetic biology can be harnessed to address some of humanity’s most pressing challenges within a short five-year time period, according to a new report released today. The report summarises the findings of a workshop held earlier this year by … |